Asia-Pacific Pneumococcal Disease Control in the Pneumococcal Conjugate Vaccine Era
Asia-Pacific Pneumococcal Disease Control in the Pneumococcal Conjugate Vaccine Era
肺炎球菌结合疫苗时代的亚太地区肺炎球菌疾病控制
批准号：
nhmrc : 1196415
负责人：
金额：
$250.0万
依托单位国家：
澳大利亚
项目类别：
Centres of Research Excellence
财政年份：
2020
资助国家：
澳大利亚
项目状态：
未结题
起止时间：
2020-01-01 至 2025-12-31
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pneumonia is one of the commonest causes of childhood death worldwide. PCV is a vaccine that prevents pneumonia but it is costly; and causes an increase in disease from strains which are not in the vaccine. Our CRE will address 2 outstanding issues: when to switch from a 3 to 2 dose PCV schedule to make it more affordable; and create new understanding of the non-vaccine strains’ impact on disease in low- and middle-income countries in the Asia-Pacific region.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
